Subtitle
Patterns of Proton Beam Therapy Use in Clinical Practice Between 2007 and 2019 in Korea.
Subtitle
Patterns of Proton Beam Therapy Use in Clinical Practice Between 2007 and 2019 in Korea.
Proto therapy Time
October 2021
Executive summary
A total of 54,035 patients had been treated with some form of RT, of whom 5,398 received PBT (10.0%). Among all types of cancer, PBT use in liver cancer has been steadily increasing from 20% in 2008-2009 to 32% in 2018-2019. Prostate cancer has been continuously decreasing from 20% in 2008-2009 to <10% in 2018-2019. Male sex, very young or old age, stage I-II disease, residency in non-capital areas, a definitive setting, a curative treatment aim, enrollment in a clinical trial, re-irradiation and insurance coverage were significantly associated with the receipt of PBT (all p < 0.05).
Key content topics
Top cancer treatments
Related contents
Webinar
April 25, 2024
Translating ConformalFLASH® from Research to Reality
Yohan
Godart
Michele
Kim
Jarrick
Nys
Proton Therapy Publication
January 2021
FLASH Radiotherapy: Current Knowledge and Future Insights Using Proton-Beam Therapy.
Webinar
Motion Management – Overview
Soufian
Audia
Proton Therapy Publication
May 2023
Proton radiotherapy in the treatment of IDH-mutant diffuse gliomas: an early experience from shanghai proton and heavy ion center.
Webinar
February 6, 2023
How to Build and Operate a Proton Therapy Facility
Steven
Frank
Darrin
Kistler
James
Metz
Matt
Palmer
Frederic
Genin
Jonathan
Weinbach
Webinar
February 6, 2023
How to De-Risk and Make Your Proton Therapy Project Successful
Steven
Frank
Matt
Palmer
David
Raubach
Jay
Shiland
Thomas
Pevenage
Podcast
January 8, 2023
Treating Patients From Around the World at S. Asia’s First Proton Center
Rakesh
Jalali
Webinar
October 23, 2022
Ramping Up to over 16 years of proton therapy experience at the University of Florida Health
Webinar
October 23, 2022
Proton Therapy Patient Selection/Triage at Corewell Health and the future of proton therapy with ARC
Craig
Stevens